[1]
2019. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer’s disease: a meta-analysis. Swiss Medical Weekly. 149, 2526 (Jun. 2019), w20093. DOI:https://doi.org/10.4414/smw.2019.20093.